An observational study in Parkinson Disease, sponsored by Neuromed IRCCS. Completed at 1 site in Italy. Open to participants aged 30 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-11-04.
Sponsored by Neuromed IRCCS · Observational
The study aims to identify genetic variants associated to Parkinson's disease through the analysis of exome-sequencing data of familial cases and controls. The identified variants will be used to generate a diagnostic tool for the identification of genetic risk profiles.
4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.
This study's enrollment of 500 is above the median of 96 across 1,057 observational studies indexed under Parkinson Disease.
Browse Parkinson Disease studies →Neuromed IRCCS is the lead sponsor of 76 studies on the registry; 23 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients will be selected from the Center for Parkinson's disease of the IRCCS Neuromed, according to specific inclusion criteria. Approximatey 500 subjects, 30 years of age or older, recruited with a family-based approach, will be included in the study.
Exclusion Criteria:
Family-based Parkinson patients carrying genetic variants associated with the disease
Family-based Control subjects
Identification of genetic variants associated with Parkinson's disease
Analysis of exome sequencing data; annotation of genetic variants; selection of variants present in cases and absent in controls
Time frame: Two years
This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Neuromed IRCCS